Wedbush Adds HealthSpring to Its Best Ideas List

Wedbush is out with its report today on HealthSpring

, adding HS to its Best Ideas List. In its report, Wedbush writes, "The Wedbush Investment Committee is adding HS to the Best Ideas List. We believe the company 1) has a sustainable cost advantage derived from owning clinics and high-quality star ratings, 2) is likely to deploy capital in the near term in what we believe will be an acquisition that is up to $0.30 per share accretive, and 3) is highly levered to the Medicare growth cycle." Wedbush maintains a $50 PT on HS. At the time of posting, shares of HS were trading at $35.72, down 0.31% from Tuesday's close.